
Arvee Laboratories (India) Sees Extraordinary Buying Interest, Hits Upper Circuit
2025-12-05 10:46:01Arvee Laboratories (India) Ltd has witnessed an exceptional surge in buying activity, with the stock hitting the upper circuit and registering only buy orders in the queue. This rare market phenomenon highlights intense investor interest and suggests the possibility of a sustained multi-day circuit scenario.
Read More
Arvee Laboratories (India) Hits Upper Circuit Amid Strong Buying Pressure
2025-12-05 10:00:31Shares of Arvee Laboratories (India) Ltd surged to hit the upper circuit limit on 5 December 2025, reflecting intense buying interest and a maximum permissible daily gain of 19.62%. The stock closed at ₹196.92, marking a significant move in the Chemicals & Petrochemicals sector, while broader market indices showed muted activity.
Read More
Arvee Laborat. Sees Revision in Market Evaluation Amid Mixed Financial Signals
2025-12-04 11:08:06Arvee Laborat., a microcap player in the Chemicals & Petrochemicals sector, has undergone a notable revision in its market evaluation metrics, reflecting a shift in analytical perspective driven by recent financial and technical developments.
Read More
Arvee Laboratories' Quality Grade Change Reflects Financial Challenges and Competitive Positioning
2025-11-18 08:01:49Arvee Laboratories (India), a microcap in the Chemicals & Petrochemicals sector, has faced challenges with a slight decline in sales and a significant drop in EBIT growth. However, it maintains a solid EBIT to interest ratio and low debt levels, with competitive performance metrics compared to industry peers.
Read MoreHow has been the historical performance of Arvee Laborat.?
2025-11-17 23:21:56Answer: The historical performance of Arvee Laborat shows significant fluctuations in key financial metrics over the years. Breakdown: Arvee Laborat's net sales have varied considerably, peaking at 62.48 Cr in March 2023 before declining to 38.49 Cr in March 2025. The total operating income followed a similar trend, reaching its highest at 62.48 Cr in March 2023 and dropping to 38.49 Cr in March 2025. The raw material cost has also seen an increase, from 18.87 Cr in March 2025 compared to 16.98 Cr in March 2024, while total expenditure excluding depreciation decreased from 54.07 Cr in March 2023 to 34.87 Cr in March 2025. Operating profit (PBDIT) has fluctuated, with a high of 8.63 Cr in March 2023 and a decrease to 4.28 Cr in March 2025. Profit before tax showed a decline from 6.17 Cr in March 2023 to 2.87 Cr in March 2025, while profit after tax also decreased from 4.12 Cr in March 2023 to 2.15 Cr in Mar...
Read More
Arvee Laboratories Q2 FY26: Revenue Plunges 72% as Profit Margins Collapse
2025-11-17 19:48:14Arvee Laboratories (India) Ltd., an Ahmedabad-based specialised chemicals manufacturer, reported deeply concerning Q2 FY26 results that signal severe operational distress. Net profit collapsed to just ₹0.01 crores from ₹0.98 crores in Q2 FY25, representing a staggering 98.98% year-on-year decline. The micro-cap company, with a market capitalisation of ₹191.00 crores, saw its stock trade at ₹167.57, up 2.52% following the results announcement, though this modest uptick does little to offset the fundamental deterioration evident in the quarterly numbers.
Read MoreHow has been the historical performance of Arvee Laborat.?
2025-11-15 00:21:21Answer: The historical performance of Arvee Laborat shows fluctuations in key financial metrics over the years. Breakdown: Arvee Laborat's net sales have varied significantly, peaking at 62.48 Cr in March 2023 and declining to 38.49 Cr by March 2025. The total operating income followed a similar trend, with a high of 62.48 Cr in March 2023 and a drop to 38.49 Cr in March 2025. Total expenditure, excluding depreciation, also saw a decrease from 54.07 Cr in March 2023 to 34.87 Cr in March 2025. Operating profit (PBDIT) reached its highest at 8.63 Cr in March 2023 but fell to 4.28 Cr by March 2025. Profit before tax mirrored this decline, dropping from 6.17 Cr in March 2023 to 2.87 Cr in March 2025, while profit after tax decreased from 4.12 Cr to 2.15 Cr in the same period. The company's earnings per share (EPS) showed a decline from 3.74 in March 2023 to 1.95 in March 2025. On the balance sheet, total liabi...
Read MoreHow has been the historical performance of Arvee Laborat.?
2025-11-13 23:44:58Answer: The historical performance of Arvee Laborat shows fluctuations in key financial metrics over the years. Breakdown: Arvee Laborat's net sales have varied significantly, peaking at 62.48 Cr in Mar'23 before declining to 38.49 Cr in Mar'25. Total operating income followed a similar trend, reaching a high of 62.48 Cr in Mar'23 and dropping to 38.49 Cr in Mar'25. The company's total expenditure, excluding depreciation, also saw a decline from 54.07 Cr in Mar'23 to 34.87 Cr in Mar'25. Operating profit (PBDIT) decreased from 8.63 Cr in Mar'23 to 4.28 Cr in Mar'25, reflecting a decline in profitability. Profit before tax and profit after tax also showed a downward trend, with profit before tax falling from 6.17 Cr in Mar'23 to 2.87 Cr in Mar'25, and profit after tax decreasing from 4.12 Cr to 2.15 Cr in the same period. The earnings per share (EPS) mirrored this decline, dropping from 3.74 in Mar'23 to 1.9...
Read MoreHow has been the historical performance of Arvee Laborat.?
2025-11-03 22:57:03Answer: The historical performance of Arvee Laborat shows fluctuations in key financial metrics over the years. Breakdown: Arvee Laborat's net sales peaked at 62.48 Cr in March 2023 but have since declined to 38.49 Cr in March 2025. Total operating income followed a similar trend, decreasing from 62.48 Cr in March 2023 to 38.49 Cr in March 2025. The company's total expenditure, excluding depreciation, was 54.07 Cr in March 2023, which reduced to 34.87 Cr by March 2025. Operating profit, excluding other income, was 3.62 Cr in March 2025, up from 3.00 Cr in March 2024, but down from 8.41 Cr in March 2023. Profit before tax also showed a decline from 6.17 Cr in March 2023 to 2.87 Cr in March 2025. Profit after tax increased from 1.05 Cr in March 2024 to 2.15 Cr in March 2025, although it was lower than the 4.12 Cr recorded in March 2023. The company's total assets decreased from 38.69 Cr in March 2023 to 38.2...
Read MoreArvee Laboratories (India) Limited - Clarification - Financial Results
03-Dec-2019 | Source : NSEArvee Laboratories (India) Limitedies (India) Limited for the quarter ended 30-Sep-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Arvee Laboratories (India) Limited - Outcome of Board Meeting
14-Nov-2019 | Source : NSEArvee Laboratories (India) Limited has informed the Exchange regarding Board meeting held on November 14, 2019.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
Arvee Laboratories (India) Ltd has announced 1:1 bonus issue, ex-date: 13 Oct 20
No Rights history available






